Abstract:Summary Background Chikungunya is an arboviral disease transmitted by Aedes aegypti and Aedes albopictus mosquitoes with a growing global burden linked to climate change and globalisation. We aimed to estimate chikungunya seroprevalence, force of infection (FOI), and prevalence of related chronic disability and hospital admissions in endemic and epidemic settings. Methods In this systematic review, meta-analysis, and modelling study, we searched PubMed, Ovid, and Web of Science for articles published from database inception until Sept 26, 2022, for prospective and retrospective cross-sectional studies that addressed serological chikungunya virus infection in any geographical region, age group, and population subgroup and for longitudinal prospective and retrospective cohort studies with data on chronic chikungunya or hospital admissions in people with chikungunya. We did a systematic review of studies on chikungunya seroprevalence and fitted catalytic models to each survey to estimate location-specific FOI (ie, the rate at which susceptible individuals acquire chikungunya infection). We performed a meta-analysis to estimate the proportion of symptomatic patients with laboratory-confirmed chikungunya who had chronic chikungunya or were admitted to hospital following infection. We used a random-effects model to assess the relationship between chronic sequelae and follow-up length using linear regression. The systematic review protocol is registered online on PROSPERO, CRD42022363102. Findings We identified 60 studies with data on seroprevalence and chronic chikungunya symptoms done across 76 locations in 38 countries, and classified 17 (22%) of 76 locations as endemic settings and 59 (78%) as epidemic settings. The global long-term median annual FOI was 0·007 (95% uncertainty interval [UI] 0·003–0·010) and varied from 0·0001 (0·00004–0·0002) to 0·113 (0·07–0·20). The highest estimated median seroprevalence at age 10 years was in south Asia (8·0% [95% UI 6·5–9·6]), followed by Latin America and the Caribbean (7·8% [4·9–14·6]), whereas median seroprevalence was lowest in the Middle East (1·0% [0·5–1·9]). We estimated that 51% (95% CI 45–58) of people with laboratory-confirmed symptomatic chikungunya had chronic disability after infection and 4% (3–5) were admitted to hospital following infection. Interpretation We inferred subnational heterogeneity in long-term average annual FOI and transmission dynamics and identified both endemic and epidemic settings across different countries. Brazil, Ethiopia, Malaysia, and India included both endemic and epidemic settings. Long-term average annual FOI was higher in epidemic settings than endemic settings. However, long-term cumulative incidence of chikungunya can be similar between large outbreaks in epidemic settings with a high FOI and endemic settings with a relatively low FOI. Funding International Vaccine Institute.

Global distribution and environmental suitability for Chikungunya virus, 1952 to 2015

The research progress of Chikungunya fever

The global epidemiology of chikungunya from 1999 to 2020: A systematic literature review to inform the development and introduction of vaccines

Regional spread of chikungunya fever in the Americas

Chikungunya virus in Asia – Pacific: a systematic review

Understanding the Transmission Dynamics of the Chikungunya Virus in Africa

Chikungunya: An Emerging Public Health Concern

Chikungunya virus infection: molecular biology, clinical characteristics, and epidemiology in Asian countries

Chikungunya Virus: An Emergent Arbovirus to the South American Continent and a Continuous Threat to the World

Chikungunya seroprevalence, force of infection, and prevalence of chronic disability after infection in endemic and epidemic settings: a systematic review, meta-analysis, and modelling study

Chikungunya infection in returned travellers: results from the geosentinel network, 2005–2020

A change in circulating chikungunya virus variant impacts Aedes aegypti vector competence and spatiotemporal distribution of disease in Malaysia

Global risk mapping for major diseases transmitted by Aedes aegypti and Aedes albopictus

A systematic review of individual and community mitigation measures for prevention and control of chikungunya virus

The evolutionary and molecular history of a chikungunya virus outbreak lineage

Genetic Characterization of Chikungunya Virus in Field-Caught Aedes aegypti Mosquitoes Collected during the Recent Outbreaks in 2019, Thailand

Tracing the evolution of the chikungunya virus in Argentina, 2016-2023: independent introductions and prominence of Latin American lineages

Current Status of Chikungunya in India

Current Epidemiological Status of Chikungunya Virus Infection in East Africa: A Systematic Review and Meta‐Analysis

Tropism of the Chikungunya Virus

Host-adaptive mutations in Chikungunya virus genome